← Insider buys
MRKR

Marker Therapeutics, Inc. · Healthcare

10% owner Ali Behbahani bought $10.0M of Marker Therapeutics, Inc.

Bought$9,999,999
$1.75Price
5,714,285Shares
+114%Stake

What MRKR did for a copier

Prices for MRKR after this filing aren't in yet.

Ali Behbahani's record

5 other buys with 3 months of prices since 2018: on average −10.1% against the S&P 500, and 2 of 5 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Tue, Mar 16. Filed Thu, Mar 18, 5:11 PM ET, after the close. Not investment advice.